Earnings calendar/IMRX
Immuneering Corp (IMRX)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Latest EPS YoY
+32.5%
vs 2025-08-13
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$360,958
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS miss
EPS actual / est
$-0.27 / $-0.26
-2.2%
Revenue actual / est
$360,958 / —
—
Result
Below target
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 8/5/2026 | $-0.26 | $-0.27 | -2.2% | — | $360,958 | — |
| 5/15/2026 | $-0.30 | $-0.21 | +30.0% | — | Pending | — |
| 5/14/2026upcoming | $-0.30 | Pending | — | — | Pending | — |
| 5/11/2026upcoming | $-0.30 | Pending | — | — | Pending | — |
| 5/4/2026upcoming | $-0.30 | Pending | — | — | Pending | — |
| 3/19/2026upcoming | $-0.31 | Pending | — | — | Pending | — |
| 3/6/2026 | $-0.31 | $-0.18 | +41.9% | — | Pending | — |
| 11/12/2025 | $-0.37 | $-0.38 | -2.7% | — | Pending | — |
| 8/13/2025 | $-0.40 | $-0.40 | 0.0% | — | Pending | — |
| 5/5/2025 | $-0.41 | $-0.42 | -2.4% | — | Pending | — |
| 3/20/2025 | $-0.42 | $-0.58 | -38.1% | — | Pending | — |
| 11/13/2024 | $-0.54 | $-0.49 | +9.3% | — | Pending | — |
| 8/6/2024 | $-0.51 | $-0.47 | +7.8% | — | Pending | — |
| 5/7/2024 | $-0.45 | $-0.49 | -8.9% | — | Pending | — |
| 3/1/2024 | $-0.48 | $-0.52 | -8.3% | — | $-94.4M | — |
| 11/9/2023 | $-0.51 | $-0.43 | +15.7% | — | Pending | — |
| 8/3/2023 | $-0.54 | $-0.43 | +20.4% | — | $94.4M | — |
| 5/4/2023 | $-0.54 | $-0.51 | +5.6% | $8,333 | Pending | — |
| 3/6/2023 | $-0.58 | $-0.50 | +13.8% | $60,000 | $456 | -99.2% |
| 11/10/2022 | $-0.48 | $-0.49 | -2.1% | $153,333 | $38,380 | -75.0% |
Need IMRX data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.